These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32830304)

  • 21. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
    Malotte K; Saguros A; Groninger H
    J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure.
    Sackner-Bernstein JD
    Curr Cardiol Rep; 2005 May; 7(3):204-10. PubMed ID: 15865862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
    Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
    Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.
    Farmakis D; Agostoni P; Baholli L; Bautin A; Comin-Colet J; Crespo-Leiro MG; Fedele F; García-Pinilla JM; Giannakoulas G; Grigioni F; Gruchała M; Gustafsson F; Harjola VP; Hasin T; Herpain A; Iliodromitis EK; Karason K; Kivikko M; Liaudet L; Ljubas-Maček J; Marini M; Masip J; Mebazaa A; Nikolaou M; Ostadal P; Põder P; Pollesello P; Polyzogopoulou E; Pölzl G; Tschope C; Varpula M; von Lewinski D; Vrtovec B; Yilmaz MB; Zima E; Parissis J
    Int J Cardiol; 2019 Dec; 297():83-90. PubMed ID: 31615650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].
    Christ M; Ludwig N; Maisch B
    Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic adjustments in stage D heart failure: challenges and strategies.
    Joyce E; Nohria A
    Curr Heart Fail Rep; 2015 Feb; 12(1):15-23. PubMed ID: 25391351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic approach to acute decompensated heart failure.
    Kapoor JR; Perazella MA
    Am J Med; 2007 Feb; 120(2):121-7. PubMed ID: 17275448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Inotropic Agents in Treatment of Systolic Heart Failure.
    Tariq S; Aronow WS
    Int J Mol Sci; 2015 Dec; 16(12):29060-8. PubMed ID: 26690127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational use of inotropic therapy in heart failure.
    Felker GM; O'Connor CM
    Curr Cardiol Rep; 2001 Mar; 3(2):108-13. PubMed ID: 11177666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Palliative inotrope therapy in advanced heart failure: organization and management].
    Gorni G; Correale M; Nodari S; Sinagra G
    G Ital Cardiol (Rome); 2020 Apr; 21(4):296-302. PubMed ID: 32202562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
    Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA
    Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure.
    Levine BS
    J Cardiovasc Nurs; 2000 Jul; 14(4):76-93. PubMed ID: 10902105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life.
    Latimer A; Pope ND; McFarlin JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Lüscher TF
    Eur Heart J; 2019 Nov; 40(44):3579-3582. PubMed ID: 31750530
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous Inotrope Therapy in Hospice Care: A Case Series.
    Patel K; D'Souza A; Groninger H
    Am J Hosp Palliat Care; 2019 Jul; 36(7):660-663. PubMed ID: 30630349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.